These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30851166)

  • 41. Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.
    Okubo H; Akiyama J; Kobayakawa M; Kawazoe M; Mishima S; Takasaki Y; Nagata N; Shimada T; Yokoi C; Komori S; Kimura K; Hisada Y; Iwata E; Watanabe K; Yanagisawa N; Shiroma S; Shimomura A; Okahara K; Cho H; Uemura N
    J Gastroenterol; 2020 Nov; 55(11):1054-1061. PubMed ID: 32930864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
    Nseir W; Diab H; Mahamid M; Abu-Elheja O; Samara M; Abid A; Mograbi J
    Aliment Pharmacol Ther; 2012 Aug; 36(3):231-8. PubMed ID: 22646167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for
    Kim BJ; Lee H; Lee YC; Jeon SW; Kim GH; Kim HS; Sung JK; Lee DH; Kim HU; Park MI; Choi IJ; Yoon SM; Kim SW; Baik GH; Lee JY; Kim JI; Kim SG; Kim J; Lee J; Kim JG; Kim JJ;
    Gut Liver; 2019 Sep; 13(5):531-540. PubMed ID: 31505907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
    Chen MJ; Chen CC; Chen YN; Chen CC; Fang YJ; Lin JT; Wu MS; Liou JM;
    Am J Gastroenterol; 2018 Oct; 113(10):1444-1457. PubMed ID: 30171216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
    Abuhammour A; Dajani A; Nounou M; Zakaria M
    Arab J Gastroenterol; 2016 Sep; 17(3):131-136. PubMed ID: 27665525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
    Pontone S; Standoli M; Angelini R; Pontone P
    Dig Liver Dis; 2010 Aug; 42(8):541-3. PubMed ID: 20061196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study.
    De Francesco V
    J Gastrointestin Liver Dis; 2019 Mar; 28(1):129-130. PubMed ID: 30851183
    [No Abstract]   [Full Text] [Related]  

  • 49. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
    De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
    Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Long X; Chen Q; Yu L; Liang X; Liu W; Lu H
    Helicobacter; 2018 Jun; 23(3):e12485. PubMed ID: 29696736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.
    Chuah SK; Liang CM; Lee CH; Chiou SS; Chiu YC; Hu ML; Wu KL; Lu LS; Chou YP; Chang KC; Kuo CH; Kuo CM; Hu TH; Tai WC
    Medicine (Baltimore); 2016 May; 95(19):e3586. PubMed ID: 27175657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
    Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
    World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.
    Nasa M; Choksey A; Phadke A; Sawant P
    Indian J Gastroenterol; 2013 Nov; 32(6):392-6. PubMed ID: 24158898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between  daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled  trial.
    Shahbazi S; Vahdat Shariatpanahi Z
    Indian J Gastroenterol; 2018 Nov; 37(6):550-554. PubMed ID: 30635887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study.
    Chuah SK; Tai WC; Hsu PI; Wu DC; Wu KL; Kuo CM; Chiu YC; Hu ML; Chou YP; Kuo YH; Liang CM; Chiu KW; Hu TH
    Helicobacter; 2012 Oct; 17(5):374-81. PubMed ID: 22967121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China.
    Qian J; Ye F; Zhang J; Yang YM; Tu HM; Jiang Q; Shang L; Pan XL; Shi RH; Zhang GX
    Helicobacter; 2012 Dec; 17(6):478-85. PubMed ID: 23067317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of sequential versus standard Helicobacter pylori eradication therapy on the associated iron deficiency anemia in children.
    Ali Habib HS; Murad HA; Amir EM; Halawa TF
    Indian J Pharmacol; 2013; 45(5):470-3. PubMed ID: 24130381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.